Parkinson’s Disease (Opicapone) - Forecast and Market Analysis to 2022

1
Opicapone (Parkinsons Disease) Forecast and
Market Analysis to 2022
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_marketoptimizer.org with
your contact details and questions if any.

• Published Mar 2014
• Single User PDF US 3495
• Corporate User PDF US 10485

2
Opicapone (Parkinsons Disease) Forecast and
Market Analysis to 2022

• Parkinsons disease is a progressive condition
  that is characterized by bradykinesia, muscular
  rigidity, tremor, and postural instability. As
  the second most common neurodegenerative
  disorder, Parkinsons disease may affect
  individuals of any age but prevalence is
  increased with age and it is most common in the
  elderly. Dopaminergic therapies have been fairly
  effective in treating bradykinesia, but several
  unmet needs remain. Some needs will be met during
  the forecast period from 2012-2022, while others,
  such as the need for disease-modifying drugs,
  will remain.
• Opicapone is a COMT inhibitor in Phase III of
  development by the Portuguese drug developer
  Bial. It is currently under investigation as an
  add-on therapy to levodopa to treat wearing-off
  in advanced Parkinsons disease patients.

Call Now 1 888 391 5441 Email at
sales_at_marketoptimizer.org
3
Opicapone (Parkinsons Disease) Forecast and
Market Analysis to 2022

• Scope
• Overview of Parkinsons disease, including
  epidemiology, etiology, symptoms, diagnosis,
  pathology and treatment guidelines as well as an
  overview on the competitive landscape.
• Detailed information on Opicapone including
  product description, safety and efficacy profiles
  as well as a SWOT analysis.
• Sales forecast for Opicapone for the top six
  countries from 2012 to 2022.
• Sales information covered for the US, France,
  Germany, Italy, Spain and the UK.
• Inquire about this report at http//www.marketopti
  mizer.org/contacts/purchase?rname7296 or Call 1
  888 391 5441

Call Now 1 888 391 5441 Email at
sales_at_marketoptimizer.org
4
Opicapone (Parkinsons Disease) Forecast and
Market Analysis to 2022

• Reasons to buy
• Understand and capitalize by identifying products
  that are most likely to ensure a robust return
• Stay ahead of the competition by understanding
  the changing competitive landscape for
  Parkinsons disease
• Effectively plan your MA and partnership
  strategies by identifying drugs with the most
  promising sales potential
• Make more informed business decisions from
  insightful and in-depth analysis of Opicapone
  performance
• Obtain sales forecast for Opicapone from
  2012-2022 in the top six countries (the US,
  France, Germany, Italy, Spain and the UK).
• Get a detailed report at http//www.marketoptimize
  r.org/opicapone-parkinsons-disease-forecast-and-ma
  rket-analysis-to-2022.html .

Call Now 1 888 391 5441 Email at
sales_at_marketoptimizer.org
5
Opicapone (Parkinsons Disease) Forecast and
Market Analysis to 2022

• About Us
• marketoptimizer.org is an online market research
  reports library of 250,000 in-depth studies of
  over 5000 micro markets. Our database includes
  reports by leading publishers from across the
  globe. We provide 24/7 online and offline support
  service to our customers. marketoptimizer.org
  also offers company data, country profiles,
  trends, information and analysis on the sector of
  your interest.
• Visit Us _at_
• http//www.marketoptimizer.org
• Follow Us

Call Now 1 888 391 5441 Email sales _at_
sales_at_marketoptimizer.org